<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>Sloan Kettering Hit With Another Controversy Over Exclusive Deal With For-Profit Startup It Has Financial Stake In - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="7rkCkfpR9G"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/sloan-kettering-hit-with-another-controversy-over-exclusive-deal-with-for-profit-startup-it-has-financial-stake-in/"&gt;Sloan Kettering Hit With Another Controversy Over Exclusive Deal With For-Profit Startup It Has Financial Stake In&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/sloan-kettering-hit-with-another-controversy-over-exclusive-deal-with-for-profit-startup-it-has-financial-stake-in/embed/#?secret=7rkCkfpR9G" width="600" height="338" title="&#x201C;Sloan Kettering Hit With Another Controversy Over Exclusive Deal With For-Profit Startup It Has Financial Stake In&#x201D; &#x2014; KFF Health News" data-secret="7rkCkfpR9G" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>Memorial Sloan Kettering Cancer Center and its officials hold an equity stake in the artificial intelligence startup to which the center has granted exclusive rights to use its vast archives. The connections raised some eyebrows so soon after the resignation of the center's chief medical officer over his failure to disclose financial conflicts.</description></oembed>
